|
1
|
Hakomori SL: Tumor malignancy defined by
aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer
Res. 56:5309–5318. 1996.PubMed/NCBI
|
|
2
|
Itzkowitz SH: Carbohydrate change in colon
carcinoma. Acta Pathol Immunol Microbiol Scand. 100:173–180.
1992.
|
|
3
|
Miyake M and Hakomori SI: A specific cell
surface glycoconjugate controlling cell motility: evidence by
functional monoclonal antibodies that inhibit cell motility and
tumor metastasis. Biochemistry. 30:3328–3334. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Le Pendu J, Marionneau S, Cailleau-Thomas
A, Rocher J, Le Moullac-Vaidye B and Clément M: ABH and Lewis
Histo-blood group antigens in cancer. APMIS. 109:9–31. 2001.
|
|
5
|
Naitoh H, Nakajima T, Nagamachi Y and
Yazawa S: A clinicopathological evaluation of anti-fucosylated
antigen antibody (YB-2) in colorectal carcinoma. Glycosylation Dis.
1:31–36. 1994. View Article : Google Scholar
|
|
6
|
Ørntof TF, Geenwell P, Clausen H and
Watkins WM: Regulation of the oncodevelopmental expression of type
1 chain ABH and Lewis(b) blood group antigens in human colon by
alpha-2-L-fucosylation. Gut. 32:287–293. 1991.PubMed/NCBI
|
|
7
|
Yazawa S, Nishimura T, Ide M, Asao T,
Okamura A, Tanaka S, Takai I, Yagihashi Y, Saniabadi AR and Kochibe
N: Tumor-related expression of α1,2fucosylated antigens on
colorectal carcinoma cells and its suppression by cell-mediated
priming using sugar acceptors for α1,2fucosyltransferase.
Glycobiology. 12:545–553. 2002.
|
|
8
|
Sun J, Thurin J, Cooper HS, Wang P,
Mackiewicz M, Steplewski Z and Blaszyk-Thurin M: Elevated
expression of H-type GDP-L-fucose:β-D-galactoside
α-2-L-fucosyltransferase is associated with human
colon-adenocarcinoma progression. Proc Natl Acad Sci USA.
92:5724–5728. 1995.PubMed/NCBI
|
|
9
|
Larsen RD, Ernst LK, Nair RP and Lowe JB:
Molecular cloning sequence and expression of human
GDP-L-fucose:β-D-galactoside 2-α-L-fucosyltransferase cDNA that can
form the H group antigen. Proc Natl Acad Sci USA. 87:6674–6678.
1990.
|
|
10
|
Rouquier S, Lowe JB, Kelly RJ, Fertitta
AL, Lennon GG and Giordi G: Molecular cloning of a human genomic
region containing the H blood group α(1,2)fucosyltransferase gene
and two H locus-related DNA restriction fragments. Isolation of a
candidate for the human secretor blood group locus. J Biol Chem.
270:4632–4639. 1995.PubMed/NCBI
|
|
11
|
Kelly RJ, Rouquier S, Giordi G, Lennon GG
and Lowe JB: Sequence and expression of a candidate for the human
secretor blood group α(1,2)fucosyltransferase gene (FUT2).
Homozygosity for an enzyme-inactivating nonsense mutation commonly
correlates with the non-secretor phenotype. J Biol Chem.
270:4640–4649. 1995.
|
|
12
|
Avent ND: Human erythrocyte antigen
expression: its molecular basis. Br J Biomed Sci. 54:16–37.
1997.PubMed/NCBI
|
|
13
|
Sarnesto A, Köhlin T, Hindsgaul O, Thurin
J and Blaszczyk-Thurin M: Purification of the secretor-type
β-galactoside α1→2fucosyltransferase from human serum. J Biol Chem.
265:15067–15075. 1990.
|
|
14
|
Yazawa S, Nakamura J, Asao T, Nagamachi Y,
Sagi M, Matta KL, Tachikawa T and Akamatsu M: Aberrant
α1→2fucosyltransferase found in human colorectal carcinoma involved
in the accumulation of Leb and Y antigens in colorectal
tumors. Jpn J Cancer Res. 84:989–995. 1993.
|
|
15
|
Sakamoto J, Furukawa K, Gordon-Cardo C,
Yin B, Retting W, Oettgen H, Old L and Lloyd K: Expression of
Lewisa, Lewisb, X and Y blood group antigens
in human colonic tumors and normal tissue and in human
tumor-derived cell lines. Cancer Res. 46:1553–1561. 1986.
|
|
16
|
Muinelo-Romay L, Vázquez-Martín C,
Villar-Portela S, Cuevas E, Gil-Martín E and Fernández-Briera A:
Expression and enzyme activity of α(1,6)fucosyltransferase in human
colorectal cancer. Int J Cancer. 123:641–646. 2008.
|
|
17
|
Mejías-Luque R, López-Ferrer A, Garrido M,
Fabra A and de Bolós C: Changes in the invasive and metastatic
capacities of HT-29/M3 cells induced by the expression of
fucosyltransferase 1. Cancer Sci. 98:1000–1005. 2007.PubMed/NCBI
|
|
18
|
Kim Y and Itzkowitz SH: Carbohydrate
antigen expression in adenocarcinoma sequence. Prog Clin Biol Res.
279:241–250. 1988.
|
|
19
|
Blaszczyc-Thurin M, Sarnesto A, Thurin J,
Hindsgaul O and Koprowski H: Biosynthetic pathway for the
Leb and Y glycolipids in the gastric carcinoma cell line
Kato III as analyzed by a novel assay. Biochem Biophys Res Commun.
151:100–108. 1988.
|
|
20
|
Goupille C, Marionneau S, Bureau V,
Hallouin F, Meichenin M, Rocher J and Le Pendu J:
α(1,2)fucosyltransferase increases resistance to apoptosis of rat
colon carcinoma cells. Glycobiology. 10:375–382. 2000.
|
|
21
|
Hallouin F, Goupille C, Bureau V, Meflash
K and Le Pendu J: Increased tumorigenicity of rat colon carcinoma
cells after α(1,2)fucosyltransferase FTA anti-sense cDNA
transfection. Int J Cancer. 80:601–611. 1999.
|
|
22
|
Nishihara S, Hiraga T, Ikehara Y, Kudo T,
Iwasaki H, Morozumi K, Akamatsu S, Tachikawa T and Narimatsu H:
Molecular mechanisms of expression of Leb antigen and
other type I Lewis antigens in human colorectal cancer.
Glycobiology. 9:607–616. 1999.
|
|
23
|
Ravn V and Dabelsteen E: Tissue
distribution of histo-blood group antigens. APMIS. 108:1–28. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Itzkowitz SH, Rajvir D, Byrd JC and Kim
YS: Blood group antigen synthesis and degradation in normal and
cancerous colonic tissues. Gastroenterology. 99:431–442.
1990.PubMed/NCBI
|
|
25
|
Chandrasekaran EV, Jain RK and Matta KL:
Expression of blood group Lewis b determinant from Lewis a:
association of this novel α(1,2)-L-fucosylating activity with the
Lewis type α(1,3/4)-L-fucosyltransferase. Biochemistry.
34:4748–4756. 1995.PubMed/NCBI
|
|
26
|
Ichikawa D, Handa K, Withers DA and
Hakomori S: Histo-blood group A/B versus H status of human
carcinoma cells as correlated with haptotactic cell motility:
approach with A and B gene transfection. Cancer Res. 57:3092–3996.
1997.PubMed/NCBI
|
|
27
|
Tsuboi K, Asao T, Ide M, Hashimoto S,
Noguchi K, Kominato Y, Saniabadi AR, Kuwano H and Yazawa S:
α(1,2)fucosylation is a superior predictor of postoperative
prognosis for colorectal cancer compared with blood group A, B, or
sialyl Lewis X antigen generated within colorectal tumor tissues.
Ann Surg Oncol. 14:1880–1889. 2007.
|
|
28
|
Moehler TM, Sauer S, Witzel M, Andrulis M,
Garcia-Vallejo JJ, Grobholz R, Willhauck-Fleckenstein M, Greiner A,
Goldschmidt H and Schwartz-Albiez R: Involvement of
α1–2-fucosyltransferase I (FUT1) and surface-expressed Lewis(y)
(CD174) in first endothelial cell-cell contacts during
angiogenesis. J Cell Physiol. 215:27–36. 2008.
|
|
29
|
Russell L, Waring P and Beaver JP:
Increased cell surface exposure of fucose residues in a late event
in apoptosis. Biochem Biophys Res Commun. 250:449–453. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kannagi R: Carbohydrate-mediated cell
adhesion involved in hematogenous metastasis of cancer. Glycoconj
J. 14:577–584. 1997. View Article : Google Scholar : PubMed/NCBI
|
